Novartis AG (BCBA:NVS)

Novartis AG Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	423,812,510	384,928,259	201,761,951	167,490,682	34,441,450	20,230,863
Market Cap Growth	104.85%	90.78%	20.46%	386.31%	70.24%	11.88%
Enterprise Value	459,244,489	418,170,027	219,476,263	178,425,590	36,247,364	23,004,268
Last Close Price	58475.00	53075.00	28593.43	23307.44	7492.87	4217.64
PE Ratio	20.88	18.97	16.39	13.95	27.96	8.20
PS Ratio	5.15	4.68	3.78	4.44	4.47	4.48
PB Ratio	6.27	5.70	4.43	4.43	3.27	2.91
P/TBV Ratio	-	-	-	-	-	21.01
P/FCF Ratio	16.59	15.07	12.04	15.46	14.60	14.07
P/OCF Ratio	15.25	13.85	11.11	14.33	13.66	13.07
EV/Sales Ratio	5.57	5.08	4.12	4.73	4.71	5.09
EV/EBITDA Ratio	13.29	12.27	10.30	12.15	14.68	14.33
EV/EBIT Ratio	16.61	15.16	13.04	21.57	22.21	20.43
EV/FCF Ratio	17.98	16.37	13.10	16.47	15.36	16.00
Debt / Equity Ratio	0.76	0.76	0.71	0.57	0.47	0.46
Debt / EBITDA Ratio	1.49	1.49	1.50	1.44	1.97	1.95
Debt / FCF Ratio	2.02	2.02	1.93	1.97	2.10	2.22
Asset Turnover	0.53	0.53	0.51	0.43	0.35	0.34
Inventory Turnover	2.27	2.27	2.20	1.91	1.67	1.65
Quick Ratio	0.82	0.82	0.78	0.88	1.00	1.25
Current Ratio	1.12	1.12	1.03	1.16	1.29	1.51
Return on Equity (ROE)	30.81%	30.81%	26.27%	16.15%	9.51%	36.80%
Return on Assets (ROA)	11.14%	11.14%	10.09%	5.88%	4.62%	5.28%
Return on Invested Capital (ROIC)	23.60%	24.47%	23.55%	15.05%	11.14%	13.29%
Return on Capital Employed (ROCE)	22.70%	22.70%	22.20%	13.90%	10.40%	10.80%
Earnings Yield	4.79%	5.27%	6.10%	7.17%	3.58%	12.19%
FCF Yield	6.03%	6.64%	8.30%	6.47%	6.85%	7.11%
Dividend Yield	1.07%	12.76%	13.93%	13.59%	8.18%	8.28%
Payout Ratio	55.91%	55.91%	63.85%	48.85%	107.92%	30.67%
Buyback Yield / Dilution	3.93%	3.93%	2.73%	4.78%	2.79%	1.57%
Total Shareholder Return	5.00%	16.69%	16.65%	18.37%	10.97%	9.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.